Article | November 1, 2022

The Ongoing Pursuit Of Manufacturing Digitalization

By Stefan Hyde, Automation Manager, Asahi Kasei Bioprocess America


The pharmaceutical industry is struggling with the exponentially growing demand for Oligo drug substance – and as the race to keep up continues, adding/onboarding knowledgeable resources becomes increasingly difficult. This means that the solution to the supply problem may very well require an evolution of the industry’s manufacturing facilities to employ Pharma 4.0™ concepts to support not only the growth of the workforce but also increased per-head productivity. New digital technologies must be implemented to reduce testing and installation time, ease training for new operators and scientists, streamline production, and deliver real-time batch results for clearance and approval.

Here we will explore what Pharm 4.0 is, the ICH Q10 model, and the benefits of digitalization.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online